The present application discloses a therapeutic agent for breast cancer which comprises 5 ((2 (4 (1 (2 hydroxyethyl)piperidin 4 yl)benzamide)pyridin 4 yl)oxy) 6 (2 methoxyethoxy) N methyl 1H indole 1 carboxamide or a pharmacologically acceptable salt thereof.